Idexx Laboratories (IDXX) Gross Margin (2009 - 2026)

Idexx Laboratories has reported Gross Margin for 18 years, with the latest figure at 64.04% in Q2 2026.

• On a quarterly basis, Gross Margin rose 142.0% year-over-year to 64.04% in Q2 2026; TTM through Jun 2026 was 62.45%, a 91.0% increase from a year earlier, with the FY2025 full-year figure at 61.8%, up 76.0% from the prior year.
• Gross Margin was 64.04% for Q2 2026 at Idexx Laboratories, up from 63.35% in the prior quarter.
• The five-year high for Gross Margin was 64.04% in Q2 2026, with the low at 58.36% in Q4 2023.
• Average Gross Margin over 5 years is 60.89%, with a median of 60.53% recorded in 2023.
• The largest YoY upside for Gross Margin was 184 bps in 2022 against a maximum downside of 91 bps in 2022.
• Over 5 years, Gross Margin stood at 58.53% in 2022, then retreated by 0 bps to 58.36% in 2023, then grew by 2 bps to 59.8% in 2024, then advanced by 1 bps to 60.35% in 2025, then gained by 6 bps to 64.04% in 2026.
• The last three Gross Margin figures came in at 64.04% (Q2 2026), 63.35% (Q1 2026), and 60.35% (Q4 2025), per Business Quant data.